Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.
Niraparib was recently funded in Canada for the maintenance treatment of ovarian cancer following platinum-based chemotherapy. However, the drug's safety profile in the real world remains uncertain. We conducted a cohort study to describe the patient population using niraparib and the proportion tha...
| Publicado en: | Current Oncology Vol. 31; no. 6; pp. 3591 - 3603 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jun2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |